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Tyrosine kinase-mediated axial motility of basal
cells revealed by intravital imaging
Jeremy Roy1,*,w, Bongki Kim1,*, Eric Hill1, Pablo Visconti2, Dario Krapf2,w, Claudio Vinegoni1, Ralph Weissleder1,
Dennis Brown1,2 & Sylvie Breton1
Epithelial cells are generally considered to be static relative to their neighbours. Basal cells in
pseudostratified epithelia display a single long cytoplasmic process that can cross the tight
junction barrier to reach the lumen. Using in vivo microscopy to visualize the epididymis, a
model system for the study of pseudostratified epithelia, we report here the surprising
discovery that these basal cell projections—which we call axiopodia—periodically extend and
retract over time. We found that axiopodia extensions and retractions follow an oscillatory
pattern. This movement, which we refer to as periodic axial motility (PAM), is controlled by
c-Src and MEK1/2–ERK1/2. Therapeutic inhibition of tyrosine kinase activity induces a
retraction of these projections. Such unexpected cell motility may reflect a novel mechanism
by which specialized epithelial cells sample the luminal environment.
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C
rosstalk between different cell types is crucial for the
dynamic function of epithelia. We previously reported that
basal cells (BCs) in pseudostratified epithelia extend an
intraepithelial narrow body projection that can cross the tight
junction barrier to survey the luminal environment. In the rat
epididymis, BCs detect luminal angiotensin II, and they then
communicate their finding to adjacent epithelial cells to increase
luminal acidification, a process that is crucial for proper sperm
maturation and storage1. This revealed that BCs are both sensors
of luminal stimuli and transmitters that modulate epithelial
function via crosstalk with neighbouring cells. Interestingly, a
heterogeneous population of BCs with intercellular projections of
various lengths was detected in all pseudostratified epithelia
examined1–6. This raises the question whether BCs are dynamic
cells that can regulate the length of their projections, or whether
there are distinct subsets of BCs, some with luminal-sensing
properties and some without. To distinguish between these
possibilities, we developed transgenic mice in which the red
fluorescent protein, tandem dimer (td) Tomato (tdTomato)7, is
expressed under the control of the promoter of keratin 5 (KRT5),
a specific marker of BCs. These mice were used in combination
with two-photon fluorescence intravital microscopy (FIVM)
to characterize the temporal and spatial characteristics of indivi-
dual BCs visualized in real time in the epididymis of living
animals8–11. We show that BCs have a dynamic structural
plasticity: they continuously extend and retract their intercellular
projections—here referred to as axiopodia—along their basal-to-
apical axis. We found that the axiopodium length follows an osci-
llatory pattern of extension/retraction, a process that is repressed
after therapeutic inhibition of tyrosine kinases, and is regulated
by the c-Src and MEK1/2/ERK1/2 pathways. We name this dyna-
mic movement of axiopodia periodic axial motility (PAM). Inhi-
bition of PAM may contribute to the adverse effect of tyrosine
kinase inhibitors used for cancer treatment on male fertility12.
Results
Generation and characterization of transgenic reporter mice.
We generated a novel transgenic mouse that expresses tdTomato
under the control of the promoter of the BC-specific gene KRT5.
PCR analysis shows expression of Cre recombinase in KRT5Cre
and KRT5Cre/tdTomatoLoxP mice (Fig. 1a, left), and expression of
the tdTomato gene in tdTomatoLoxP and KRT5Cre/tdTomatoLoxP
mice (Fig. 1a, right). These results indicate the expression
of tdTomato in KRT5-expressing cells in the KRT5Cre/
tdTomatoLoxP mice. This is confirmed with immunofluorescence
examination of the proximal epididymis (initial segment: IS;
Fig. 1b,c, Supplementary Movie 1), prostate (Fig. 1d), seminal
vesicles (Fig. 1e) and trachea (Fig. 1f). Double immunolabelling for
KRT5 (green) confirms expression of tdTomato in BCs. Several
tdTomato-positive BCs have an intercellular projection extending
in the direction of the lumen (axiopodia; arrows). No tdTomato
fluorescence is detected in the efferent ducts, which do not contain
BCs. These results indicate that the presence of axiopodia is a
common feature of BCs in pseudostratified epithelia.
Three-dimensional imaging of BCs using confocal microscopy.
We then examined tdTomato-positive BCs in the epididymis
using confocal laser scanning microscopy and electron micro-
scopy. Different confocal imaging views of the same cell (Fig. 2a–
c, see also immunofluorescence examination of the proximal
epididymis (IS; Fig. 1b,c and Supplementary Movie 2)) clearly
demonstrate that the axiopodium of the BC (red) reaches the
luminal compartment by crossing the tight junction barrier,
labelled for ZO-1 (green). Figure 2d shows a three-dimensional
(3D) reconstruction of another tdTomato-positive BC
superimposed with a bright-field differential interference contrast
image, also showing that its axiopodium is in contact with the
luminal side of the epithelium (see also immunofluorescence
examination of the proximal epididymis (IS; Fig. 1b,c and
Supplementary Movie 3). This is confirmed using electron
microscopy of a BC, after pre-embedding labelling with an
antibody against tdTomato (Fig. 2e; see also immunofluorescence
examination of the proximal epididymis (IS; Fig. 1b,c and
Supplementary Movie 4). In this image, the apical region of a BC
is visualized in serial ultrathin sections, which were then super-
imposed to generate a 3D projection view of the cell. This
high-resolution image shows the presence of small transepithelial
microvillar (TEM) projections (arrow) emanating from the
portion of the cell that is in contact with the luminal
compartment.
Four-dimensional imaging of BCs using FIVM. We tested here
the hypothesis that BCs are dynamic cells that undergo mor-
phological plasticity by imaging the epididymis of KRT5Cre/
tdTomatoLoxP mice in real time and in vivo using two-photon
FIVM8–11. The epididymis is an ideal organ for FIVM: located in
the scrotal sac, it is easily externalized and does not require post-
acquisition motion artefact correction11. We developed a
minimally invasive surgical procedure to expose the epididymis
while maintaining the blood flow and connection to the testis
intact (Fig. 3a). The IS was first visualized at low magnification
(Fig. 3b; see also immunofluorescence examination of the proximal
epididymis (IS; Fig. 1b,c, Supplementary Movie 5 and Supple-
mentary Fig. 1)). Higher-magnification 3D reconstructions of
single BCs, identified by their red fluorescence, were then generated
(Fig. 3c; see also immunofluorescence examination of the proximal
epididymis (IS; Fig. 1b,c and Supplementary Movie 6)). Figure 3d
(top panel) shows a filmstrip of the projected view of a single
representative BC imaged every 15min for 150min from a control
mouse. Arrows denote the tip of the BC axiopodium. The length of
this BC is plotted over time in Fig. 3d (top right panel). A curve
fitting analysis (black line) shows an oscillatory pattern of
retraction followed by extension of the BC axiopodium, with an
amplitude (maximum lengthminimum length) of 7mm—
representing 17% of the axiopodium maximum length—and a
period of T¼ 135min. Examination of several BCs in different
mice showed a similar oscillatory movement pattern. Each
individual BC has its own phase of oscillation. To allow for a
systematic comparison of their retraction and elongation, all
individual BC data sets were synchronized in time (Fig. 3e). A
curve fitting analysis shows that, on average, BC axiopodia exhibit
an oscillatory pattern of retraction and extension, with an
amplitude of 5mm in control mice (blue line: n¼ 9 BCs from six
mice, R2¼ 0.8553). We term this movement pattern PAM.
Tyrosine kinases play a crucial role in male fertility and are
major regulators of epithelial cell differentiation in the male
reproductive tract13–17. Importantly, tyrosine kinase inhibitors,
including SKI606 (also known as Bosulif or Bosutinib), were
recently approved for the treatment of some cancers18. These
drugs were suggested to have adverse effects on male fertility12,
and we tested here the effect of SKI606 on axiopodia plasticity. To
do so, SKI606 (30mg kg 1) was injected through the tail vein
while BCs were examined every 15min using FIVM. As shown
in Fig. 3d, after an initial elongation of the BC axiopodium
(bottom panels), a retraction is initiated 30min after injection,
and the axiopodium becomes 14mm smaller after 3 h. Visuali-
zation of several BCs under these conditions confirmed this
pattern (Fig. 3e, red circles and red line, n¼ 7 BCs from three
mice). On average, BCs start near their maximum length and
their axiopodia become 12±2 mm (mean±s.e.m.) shorter over a
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3-h period in the presence of SKI606. In control mice, the velocity
of movement at which BC axiopodia extend, calculated from the
slope between the minimum and maximum BC lengths, is
4.2±0.6 mmh 1, whereas in SKI606-treated mice the speed is
reversed in direction to  3.6±0.6 mmh 1 (Fig. 3e, right panel).
We further explored the inhibitory effect of SKI606 on PAM
by examining a larger population of BCs with conventional
fluorescence microscopy. After FIVM imaging, each epididymis
was fixed and cryosections were made. BCs were examined and
distributed into different categories depending on the length of
their axiopodia. SKI606 induces a significant reduction in the
percentage of BCs with long axiopodia that reached the apical
border of the epithelium (9.3±0.5% versus 18.9±2.5%, n¼ 3
SKI606-treated versus n¼ 7 control mice; Po0.05 by analysis of
variance (ANOVA) followed by Student’s t-test) and a significant
increase in the number of BCs with no axiopodia (22.1%±1.3%
versus 17.8±2.0%; Po0.05 by ANOVA followed by Student’s
t-test). These results further demonstrate the retraction of BC
axiopodia induced by SKI606.
The c-Src signalling pathway regulates PAM. SKI606 inhibits a
variety of tyrosine kinases including the non-receptor tyrosine
kinase cellular-sarcoma c-Src18. We tested the effect of SKI606 on
c-Src phosphorylation using an antibody that recognizes c-Src
when phosphorylated at residue Tyr416 (the active form of c-Src).
We found a significant reduction in c-Src Tyr416 phosphorylation
(c-Src-pTyr416) in the IS of SKI606-treated mice compared with
controls (Fig. 4a), showing efficacy of the treatment and
confirming c-Src kinase inhibition by SKI606. The specificity of
this antibody for c-Src-pTyr416 has been shown previously
in capacitated spermatozoa19. In addition, its specificity was
further demonstrated by the absence of labelling in epididymal
BCs in c-Src knockout (KO) mice compared with WT mice
(Supplementary Fig. 2).
Higher-magnification images of BC-tdTomato mouse epidi-
dymis using an antibody that recognizes total c-Src showed
enrichment of the protein in tdTomato-positive BCs (arrows)
compared with adjacent epithelial cells (Fig. 4bA–C). c-Src is
distributed throughout the cytoplasm and nucleus of BCs. A
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Figure 1 | Characterization of KRT5Cre/tdTomatoLoxP mice. (a) PCR detection of Cre recombinase and tdTomato from genomic DNA. The Cre
recombinase gene was detected in KRT5Cre and KRT5Cre/tdTomatoLoxP mice, but not in WTand tdTomatoLoxP mice (left). The tdTomato gene was detected
in DNA isolated from tdTomatoLoxP and KRT5Cre/tdTomatoLoxP mice, but not from WT and KRT5Cre mice (right). No products were detected in the H2O
lanes. (b) Proximal epididymis visualized by epifluorescence microscopy (left), and together with differential interference contrast (right). Strong tdTomato
fluorescence (red) was detected in a subset of epithelial cells, identified as BCs by the location of their nuclei (blue) in the basal region of the epithelium.
Several BCs with long intercellular cell body projections (axiopodia) were detected (arrows). Double-labelling for KRT5 (green) confirmed expression of
tdTomato in BCs in the proximal epididymis ((c) see also immunofluorescence examination of the proximal epididymis (IS; Fig. 1b,c and Supplementary
Movie 1)), prostate (d), seminal vesicles (e) and trachea (f). In all these pseudostratified epithelia, a subset of BCs have an axiopodium extending in the
direction of the lumen (arrows). Nuclei are labelled in blue with 4,6-diamidino-2-phenylindole (DAPI). Scale bars (b,d), 10mm; (c,d (inset), e,f), 5mm.
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weaker c-Src signal is also detected in adjacent principal cells.
Phosphorylated c-Src at the Tyr416 residue is detected along the
membrane of tdTomato-positive BCs (Fig. 4bD–F; arrows), as
well as in the apical stereocilia of principal cells (double-tailed
arrows). Some cells located below tdTomato-positive BCs are also
positive for c-Src-pTyr416 (arrowheads). The participation of
c-Src in the regulation of BC axiopodia PAM was examined using
c-Src KO mice. The epididymides of c-Src KO and their wild-type
(WT) littermates were labelled for KRT5, and the morphological
characteristics of BCs were examined (Fig. 4c). Very few BCs with
an axiopodium are observed in the c-Src KO mice compared with
WT (top panels). Quantification shows a significant decrease in
the number of BCs with (1) long axiopodia that reached the apical
border of the epithelium (top panels: arrow, bottom panel: apical
reaching); (2) axiopodia that reached past the rows formed by the
nuclei in adjacent principal cells (top panels: arrowheads, bottom
panel: past nucleus); and (3) short axiopodia (bottom panel:
short) in c-Src KO mice compared with WTs. A concomitant
increase in the number of BCs with no axiopodia (bottom panel:
none) is observed in c-Src KO mice. There is no statistically
significant difference in the total number of BCs per tubule cross-
sections.
MEK1/2/ERK1/2 signalling regulates axiopodium formation.
The epididymal IS is a region characterized by a high level of
ERK1/2 phosphorylation (pERK1/2)20–22. c-Src was shown to
mediate androgen-dependent pERK1/2 in an epididymal cell
line23. We, therefore, investigated whether the decrease in BC
axiopodia length observed in c-Src KO mice was associated with a
change in pERK1/2 in this region. As shown in Fig. 4d, the IS in
c-Src KO mice has reduced pERK1/2 compared with their WT
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Figure 2 | Basal cell axiopodia can cross the tight junction barrier. (a–c) Laser scanning confocal microscope images of a 16-mm cryosection of the
proximal epididymis of a KRT5Cre/tdTomatoLoxP mouse labelled for the tight junction marker ZO-1 (green), showing an extended focus view (a), slice view
(b) and a still image of a 3D reconstruction of the BC (c; see immunofluorescence examination of the proximal epididymis (IS; Fig. 1b,c and Supplementary
Movie 2)). All images show that the axiopodium of the tdTomato-positive BC (red; arrows) is in contact with the luminal side of the epithelium, delineated
by the ZO-1-labelled tight junctions. (d) 3D reconstruction of another tdTomato-positive BC, superimposed on a differential interference contrast image,
showing that its axiopodium is in contact with the luminal compartment (arrow; see also immunofluorescence examination of the proximal epididymis
(IS; Fig. 1b,c and Supplementary Movie 3). Nuclei and sperm are labelled in blue with DAPI. (e) Epididymis was immunostained using an antibody
that recognizes tdTomato, and a stack of ultrathin serial sections were obtained using electron microscopy. Images from these serial sections were
superimposed using Fiji and imported into the Volocity software to generate a ‘3D’ projection view of the cells. The ‘apical’ pole of this BC is in contact with
the luminal compartment and shows the presence of numerous short TEM (arrow, see also immunofluorescence examination of the proximal epididymis
(IS; Fig. 1b,c and Supplementary Movie 4). Longer stereocilia emanating from adjacent principal cells are also seen. Scale bars (a–d), 5mm; (e), 2 mm.
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littermates. These results indicate that the decrease in the number
of BCs with axiopodia in c-Src KO mice correlates with a decrease
in pERK1/2.
We further analysed the role of pERK1/2 in the maintenance of
BC axiopodia by treating WT mice with the MEK1/2 inhibitor
PD325901 via daily intraperitoneal injections (10mg kg 1).
Immunofluorescence shows stronger pERK1/2 labelling (red) in
the IS compared with the caput region of control mice (Fig. 5a,
top panel, Control). A progressive reduction in pERK1/2 labelling
is observed after 24 h of treatment with PD325901, and an almost
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Figure 3 | Periodic axial motility of BC axiopodia visualized by two-photon FIVM. (a) Excitation light (red beam) from a Ti:sapphire laser (L) is directed
into a laser scanning microscope (SM) and focused onto the exposed epididymis. Emitted fluorescence (green beam) is epi-collected after reflection from a
dichroic mirror (DCM), and filtered with a bandpass filter (F) before non-descanned detection (PMT). Acquisition, automatic positioning and axial
coordinates are controlled by a computer (PC). Inset: The exposed epididymis was immersed in a thermal bath and a water immersion objective was
positioned over the surface of the IS. (b) A stack of optical images was acquired along the z axis through the thickness of the IS tubule (see also
immunofluorescence examination of the proximal epididymis (IS; Fig. 1b,c, Supplementary Movie 5 and Supplementary Fig. 1). In the bottom left panel,
arrows show BC axiopodia that extend towards the lumen (L). (c) 3D reconstruction of a single BC from a higher-magnification Z-stack series (see also
immunofluorescence examination of the proximal epididymis (IS; Fig. 1b,c and Supplementary Movie 6). (d) Top left panel: time-lapse images of an
individual live BC from a control mouse. The arrows show the tip of the axiopodium visualized at 15-min intervals. The length of this BC, taken from the base
of the cell to the tip of the axiopodium, was plotted over time (top, right panel). The line shows the best-fit curve for this data set. Bottom, left panel: time-
lapse images of an individual live BC from a SKI606-treated mouse. The length of this BC was plotted over time (bottom, right panel). The line shows the
best-fit curve for this data set. (e) Left: average BC length (L) plotted versus time. Individual BC data sets were synchronized in time according to the
maximum length LMj measured for each cell Cj. The difference in length from this maximum value (DL(t)¼ Lj(t) LMj) was calculated for each cell Cj and
the average values (mean±s.e.m.) were plotted versus time (control: blue lozenges, SKI606-treated: red circles). The lines show the best-fit curve for each
data set (control: blue line, SKI-treated: red line). Right: variation of BC length versus time: Dmmh 1 for control and SKI606-treated animals. The positive
value indicates elongation and the negative value indicates retraction of BC axiopodia.
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complete disappearance of pERK1/2 is observed after 36 h in the
IS. The progressive decrease in pERK1/2 by PD325901 is
confirmed with western blot analysis, while total ERK remained
unchanged (Fig. 5c). After a 36-h treatment with PD325901, mice
were allowed to recover without the drug for 36 and 72 h. During
that recovery period, pERK returned back to normal level (Fig. 5a,
top panels, and Fig. 5c). BC morphology was assessed in
epididymis sections double-labelled for KRT5 (green) and the
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lateral membrane marker E-cadherin (red; Fig. 5a, middle
panels). The KRT5 labelling alone is displayed in black and
white in the bottom panels of Fig. 5a. Quantification of several
hundreds of BCs shows a progressive reduction in the number of
BCs with axiopodia after 24 and 36 h, and a progressive increase
in the number of BCs with axiopodia during the recovery period
(Fig. 5b, left panel). Interestingly, the ratio of BCs with long
axiopodia (Fig. 5b, right panel, white bars) to BCs with short
axiopodia (Fig. 5b, right panel, grey bars) was reversed during the
recovery period compared with controls. These results confirm
the role of the MEK1/2/ERK1/2 pathway in the regulation of BC
morphological plasticity.
The reduction in pERK1/2 that we observed in c-Src KO
mice indicates that c-Src-related events are located upstream of
MEK1/2. This is confirmed by the absence of effect of PD325901
on c-Src Tyr416 phosphorylation (Fig. 5d) while pERK1/2 levels
are markedly reduced, and by a significant reduction in ERK1/2
phosphorylation, observed by immunofluorescence, in the IS of
SKI606-treated mice compared with controls (Fig. 5e).
Proposed model of BC axiopodium motility. Figure 6 shows our
proposed model for the periodic pattern of elongation/retraction
of BC axiopodia. BCs with several morphological characteristics
can be visualized among adjacent epithelial cells in the proximal
epididymis, from BCs that have no axiopodia to BCs with variable
axiopodium lengths (Fig. 6a). Some BC axiopodia can cross the
tight junction barrier and then exhibit small TEM (arrow) that
are in contact with the luminal compartment. Figure 6b illustrates
our 4D model of the structural plasticity of a given BC as a
function of time. According to this model, each BC elongates and
retracts its axiopodium in an oscillatory manner, a process that
we name PAM (see also immunofluorescence examination of the
proximal epididymis (IS; Fig. 1b,c and Supplementary Movie 7).
The curve fit analysis shown in Fig. 3e estimates an averaged
period for PAM of 135min and amplitude of 5 mm, and a max-
imum speed of extension of 4.2 mmh 1. Figure 6c shows the
retraction of BC axiopodia after therapeutic inhibition of tyrosine
kinases with SKI606, pharmacologic inhibition of MEK1/2 or
after c-Src depletion in KO mice.
Discussion
Using a novel KRT5Cre/tdTomatoLoxP transgenic mouse that
expresses tdTomato in BCs, we show that pseudostratified
epithelia, including the trachea, epididymis, prostate and seminal
vesicles, contain BCs that extend a narrow intercellular projec-
tion along their basal-to-apical axis in the direction of the lumen.
These projections, which we term axiopodia, can cross the
epithelial tight junctions to reach the lumen of the organ. In the
epididymis, they then produce small TEM that are in contact with
the luminal compartment. A 4D FIVM analysis of the structural
plasticity of tdTomato-positive BCs in the epididymis revealed
that each axiopodium constitutively retracts and elongates. The
retraction/elongation movement of BC axiopodia follows an
oscillatory pattern, a process that we call PAM.
The proximal epididymis receives lumicrine factors that are
secreted by the testis and which, together with androgens,
contribute to activating the MEK1/2-ER1/2 pathway20–22. In
Lumen TEM
T = 135 min
L(t
)
t
L(t
)
3 h 36 h
Tyrosine kinase or MEK1/2-ERK1/2
inhibition or c-Src depletion
5 μm
12 μm
a
b
c
Figure 6 | Model of BC plasticity. (a) BCs (red) with axiopodia of different
lengths are present in pseudostratified epithelia. Some axiopodia can cross
the tight junction barrier and then exhibit small TEM (arrow). (b) Variation
of the length of individual BC axiopodia as a function of time under control
conditions. Each axiopodium extends and retracts in a periodic pattern.
On average, the period of oscillation is 135min and the amplitude is 5 mm
(see also immunofluorescence examination of the proximal epididymis
(IS; Fig. 1b,c and Supplementary Movie 7). (c) Therapeutic tyrosine kinase
inhibition, pharmacologic MEK1/2 inhibition or genetic depletion of c-Src
induce a progressive retraction of the BC axiopodia. After 3 h, the axiopodia
are shorter by an average value of 12 mm, and, after 36 h, most BCs have
retracted their axiopodia.
Figure 5 | Role of MEK1/2–ERK1/2 in the formation of BC axiopodia. (a) The proximal epididymis was labelled for ERK1/2 (top panels), KRT5 (green:
middle panels, white: bottom panels) and E-cadherin (red: middle panels), from control mice, mice treated with PD325901 for 24 and 36 h, and mice
allowed to recover for 36 and 72 h. Arrows show long axiopodia that reach the apical pole of the epithelium (above the row formed by principal cell nuclei)
and arrowheads show short axiopodia. (b) Left: quantification showing a progressive reduction in the number of BCs with axiopodia of all lengths after 24
and 36 h of PD325901 treatment and a progressive recovery after removal of the drug. Right: in control and PD325901-treated mice the number of BCs
with long axiopodia is lower than the number of BCs with short axiopodia. During the recovery period, BCs with long axiopodia are more numerous than
BCs with short axiopodia. (c) Western blot of proximal epididymis showing that PD325901 induced a progressive reduction in ERK1/2 phosphorylation,
while total ERK1/2 remained unaffected. ERK1/2 phosphorylation returned back to normal after removal of the drug. b-actin was used as a loading control.
(d) Left: western blots of epididymal IS showing that 36-h treatment with PD325901 had no effect on c-SrcTyr416 phosphorylation and total c-Src
protein content. Here again a marked reduction in ERK1/2 phosphorylation was observed. Right: levels of phosphorylated c-Src and ERK1/2 were
normalized to their respective total protein levels. Data are means±s.e.m. from four mice. *Po0.001 by ANOVA followed by Student’s t-test. (e) Left:
immunofluorescence detection of pERK1/2 showing a significant reduction in phosphorylation levels in the IS of mice after 36 h treatment with SKI606
compared with controls. Right: significant reduction in pERK1/2-associated mean pixel intensity in the IS of SKI606-treated mice compared with controls.
*Po0.001. Scale bars, 50mm.
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addition, the tyrosine kinase c-Src was shown to mediate
androgen-dependent pERK1/2 in an epididymal cell line23.
c-Src plays essential roles in sperm activation and in the
regulation of epithelial cell differentiation in the
epididymis14,24,25. Importantly, tyrosine kinase inhibitors,
including SKI606, are currently used for the treatment of some
cancers18. However, these drugs have adverse effects on male
fertility12. We show here that tyrosine kinase inhibition with
SKI606 induced axiopodia retraction in BCs. Our study, thus,
provides a potential mechanism by which male fertility might be
impaired following treatment with anticancer drugs that target
the tyrosine kinase pathway. After a short treatment of 3 h, BC
axiopodia were on average 12 mm shorter (approximately 30%
shorter than the axiopodium maximal length); however, we
anticipate that the amplitude of retraction would have become
even greater with time if we could have visualized the cells for
longer periods of time in the living animal. In agreement with this
notion, we found using fixed tissues that most BCs had
completely retracted their axiopodia after 24 and 36 h of
treatment with the MEK1/2 inhibitor PD325901.
We recently showed that luminal factors secreted by the testis
regulate BC intercellular projections in the mouse proximal
epididymis2. As mentioned above, these factors activate MEK1/2
and ERK1/2 (refs 20–22), which we show here are the key
regulators of PAM in BCs. In addition, c-Src might be one of the
tyrosine kinases that participate in the impairment of male
fertility resulting from cancer treatment. Indeed, our study shows
that in the epididymis c-Src regulates BC axiopodia formation via
the MEK1/2 pathway, in agreement with a previous study
showing its participation in androgen-dependent pERK1/2 in
epididymal cells23. Our results are also consistent with our
previous study showing that c-Src KO mice have a poorly
differentiated distal epididymis14.
We show here that BCs have the remarkable ability of changing
their shape by first elongating a long and slender intercellular
body projection (an axiopodium), and then by producing smaller
TEM extensions. This dynamic plasticity implies a complex
interplay between membrane protein and lipid composition,
physical forces applied to the membrane surface, intracellular
signalling pathways and cytoskeletal rearrangement, some of
which have been implicated in the plasticity of other structurally
dynamic cell types26,27. The formation of membrane protrusions
is generally regulated by the actin cytoskeleton26; however, in
some cells it is modulated by microtubules28. To determine
whether BCs use actin filaments and/or microtubules to elongate
their axiopodia and form apical microvilli will require additional
work. In our study, the role of c-Src in modulating the formation
of axiopodia in BCs is in agreement with a previous report
showing abundant c-Src expression in platelets27, and the role of
c-Src and ERK in the regulation of lamellipodium formation in
migrating cells26. Activated c-Src is attached to the inner face of
the plasma membrane and co-purifies with lipid rafts27. c-Src is
an effector and regulator of specific receptors, including
epidermal growth factor receptor (EGFR)29–31, and EGFR
regulates the formation of lamellipodia26. EGF is among the
luminal factors secreted by the testis32, and BCs express EGFR33.
Altogether, these previous results and the present study indicate
the potential participation of EGFR and lipid rafts via c-Src
signalling in the membrane curvature that takes place at the site
of membrane extension in BCs.
Membrane protrusions are often associated with cell migration.
However, the BC main body remains anchored within the
epithelium even after axiopodium formation and elongation. The
unexpected highly dynamic property of BC axiopodia might
ensure regular and efficient sampling and decoding of luminal
signals. Because they are not always in contact with the luminal
compartment, BCs are less likely to have desensitized receptors,
therefore providing a uniform response to constant luminal
signals. For example, in the rat epididymis BCs sense luminal
angiotensin II via the angiotensin II type II receptor, which then
triggers the production of nitric oxide, followed by activation the
cGMP pathway and proton secretion in adjacent proton-secreting
clear cells via a crosstalk mechanism1. Spermatozoa are a source
of ANGII, and this complex intercellular communication network
might provide a means by which clear cells maintain an acidic
luminal environment that is essential for proper sperm
maturation and storage. Interestingly, at a given time not all
BCs are in contact with the lumen. However, they form an
elaborate network at the base of the epithelium and are connected
via gap junctions3,4,6,34,35. Thus, a few luminal-sampling BCs
might serve as sentinels that could propagate signals to adjacent
BCs, which would then regulate other cell types within the
epithelium via crosstalk. This complex intercellular network
would provide several control levels for the precise regulation of
epithelial function by luminal signals.
In summary, we show here a previously unrecognized dynamic
structural plasticity of epithelial BCs. In all pseudostratified
epithelia examined, including the trachea, epididymis, prostate
and seminal vesicles, BCs exhibit a narrow body projection, which
we term an axiopodium, between adjacent epithelial cells in the
direction of the lumen. Using the epididymis as a model system,
we show that BCs constitutively extend and retract their
axiopodium in an oscillatory manner, a process that we have
named PAM. At a given time point, some BCs have their
axiopodium in contact with the luminal side of the epithelium,
and their ‘apical’ surface is then characterized by the presence of
small TEM. Pharmacologic or genetic inhibition of the s-Src and
MEK1/2–ERK1/2 pathways and therapeutic inhibition of tyrosine
kinases induced a progressive retraction of BC axiopodia. These
previously unknown effects may explain observed toxicities of
some tyrosine kinase inhibitors, and might also provide novel
therapeutic opportunities. Furthermore, the unexpected highly
dynamic motility of BCs might be part of a sophisticated
communication network, allowing efficient sampling and decod-
ing of luminal signals in pseudostratified epithelia.
Methods
Animals. KRT5Cre/tdTomatoLoxP transgenic mice were generated by mating
FVB.Cg-Tg(KRT1-5-cre)5132Jlj/Mmnc mice (KRT5Cre, Mutant Mouse
Regional Resource Centers) with the Cre reporter mice B6.Cg-Gt(ROSA)
26Sortm14(CAG-tdTomato)/Hze/J (tdTomatoLoxP, Jackson Immunoresearch
Laboratories). These mice express the red fluorescent protein, tdTomato, under the
control of the bovine KRT5 promoter. Only F1 generations of mice between the
ages of 90 and 120 days were examined in this study. WT (FVB/N) mice were used
as controls. All animals were housed and used in compliance with the Institutional
Animal Care and Use Committees of the Massachusetts General Hospital (MGH),
and in accordance with the National Institutes of Health Guide for the Care and
Use of Laboratory Animals. Animals had free access to water and were kept on a
standard food diet ad libitum. Age-matched (49–56 days old) c-Src KO and their
littermates were also examined and have been described previously14,16. Nembutal
(Pentobarbital; 60mg kg 1 wt ip) was used to anaesthetize the animals during
experimental procedures.
PCR genotyping. Tail biopsy specimens were collected from WTs, KRT5Cre,
tdTomatoLoxP and KRT5Cre/tdTomatoLoxP animals. Genomic DNA was isolated
using DNeasy Blood & Tissue kit from Qiagen (Valencia, CA, USA) following
the manufacturer’s protocol. The Cre gene was amplified using the following
primers:
50-CATTACCGGTCGATGCAACGAGTGATGAG-30 (forward) and
50-GAGTGAACGAACCTGGTCGAAATCAGTGCG-30 (reverse) producing an
amplicon of 408 bp. The tdTomato gene was amplified using the following primers:
50-CTGTTCCTGTACGGCATGG-30 (forward) and 50-GGCATTAAAGCAGC
GTATCC-30 (reverse) producing an amplicon of 196 bp. PCR amplification was
performed in 20ml aliquots containing (in mM): 1.25 MgCl2, 1 PCR buffer, 0.2
deoxynucleotide mix, 0.005 forward primer, 0.005 reverse primer and 1.25U of
Taq polymerase (all from Applied Biosciences). PCR amplification was performed
with the following parameters: 8min at 95 C, 30 s at 95 C, 30 s at 60 C, 1min at
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72 C for 35 cycles, followed by a 10-min final extension at 72 C. PCR products
were separated with gel electrophoresis on a 2% agarose gel containing Gelstar
(Lonza, Rockland, ME).
Tissue collection. Epididymis tissues were fixed by immersion in a
paraformaldehyde–lysine–periodate solution containing 4% v/v paraformaldehyde,
75mM lysine, 10mM sodium periodate and 5% w/v sucrose in 100mM phosphate
buffered saline (PBS) at room temperature for 4 h, or overnight at 4 C. Tissues
were washed with PBS three times and stored in 0.02% sodium azide–PBS.
Cryosections of 5 and 16mm thickness were collected from epididymides that
were cryoprotected in 30% sucrose overnight at 4 C and embedded in Tissue-Tek
optimum cutting temperature (OCT) compound (Sakura Finetek, Torrance, CA).
Cryosections were cut using a Leica CM3050-S microtome (Leica Microsystems,
Buffalo, IL) and collected onto Fisherbrand Superfrost Plus microscope slides
(Fisher Scientific, Pittsburg, PA).
Immunofluorescence. Single- and double-immunofluorescence labelling was
preformed as previously described1,36,37. Primary antibodies used are against the
following: KRT5 (Abcam, ab53121, 1:500 dilution), E-cadherin (BD Biosciences,
610181, 1:500 dilution), ZO-1 (a generous gift from Dr Eveline Schneeberger, 1:1),
phospho-specific (Thr202/Tyr204) p44/42 MAPK (ERK1/2, Cell Signaling
Technology, Cat# 4370, 1:100), total ERK1/2 (Cell Signaling Technology,
Cat# 4695, 1:100), total c-Src (Cell Signaling Technology, Cat# 2109, 1:100) and
phospho-specific (pTyr416) c-Src (EMD Millipore, PK1109, 1:50). A heat
antigen-retrieval procedure was employed for phospho-specific (pTyr416) c-Src
immunolabelling that consisted of microwaving the cryosections for 4min in
10mM TRIS and 1mM EDTA at pH 9.0. Affinity-purified donkey FITC-
conjugated anti-rabbit secondary IgG, donkey FITC-conjugated anti-rat secondary
IgG and donkey Cy3-conjugated anti-mouse secondary IgG were used following
the manufacturer’s protocol (Jackson Immunoresearch Laboratories). Nuclei were
labelled with 4,6-diamidino-2-phenylindole. Images were taken on a Nikon A1R
confocal microscope equipped with a motorized piezo z stage. Multiple optical
sections taken along the z axis were acquired to produce the extended focus images
and 3D reconstructions shown in some figures. BC axiopodia were divided into
four classifications. ‘Apical reaching’ axiopodia were defined as projections that
reach the lumen or the apical border of the epithelium. ‘Past nucleus’ axiopodia
were defined as projections that past the row formed by the nucleus of adjacent
principal cells. ‘Short projections’ were defined as axiopodia that are present on
BCs but do not extend past adjacent principal cell nuclei.
Pre-embedding electron microscopy labelling. Epididymides were collected
from KRT5Cre/tdTomatoLoxP transgenic mice and were immersion-fixed in
paraformaldehyde–lysine–periodate for 4 h. The tissues were washed in 1 PBS,
and the IS and caput were isolated. They were cryoprotected in 1 PBS/30%
Sucrose/0.02% Sodium Azide, OCT-embedded and sectioned at a 100-mm thick-
ness. The sections were collected into 1 PBS/0.02% Sodium Azide as free-floating
sections. The sections were then washed to remove OCT and cryoprotectant in
preparation for pre-embedding labelling.
Sections were first quenched with 0.3% H2O2 for 10min to remove any
endogenous peroxidase activity. They were then washed and blocked in a
permeabilization buffer containing 1 PBS/1% bovine serum albumin/0.2%
Gelatin/0.05% Saponin for 1 h at room temperature. An anti-DsRed/tdTomato
antibody (Clontech #632496), diluted at 1:50, was applied to the sections for
incubation overnight at 4 C. The sections were then washed with the
permeabilization buffer, and incubated with an anti-rabbit biotinylated secondary
antibody (Jackson Immunoresearch Laboratories, West Grove, PA, #711-065-152),
diluted at 1:200, for 2 h at room temperature. Sections were washed with the
permeabilization buffer and then incubated with a streptavidin/horseradish
peroxidase solution (Vector Labs Vectastain ABC kit #PK-4001) for 2 h at room
temperature. Sections were then post-fixed in 1 PBS/1% glutaraldehyde/5%
sucrose for 30min and washed in 0.05M Tris pH 7.6/7.5% sucrose in preparation
for 3,30-diaminobenzidine tetrahydrochloride (DAB-HCL, EMS #13082) reaction.
Each section was transferred onto slides and was incubated in 1ml of DAB-HCL
solution for 10min. One microlitre of a 1% H2O2 solution was added to each
section to catalyse the reaction, and sections were monitored for reaction intensity
using a stereomicroscope (Nikon SMZ645). When sufficient intensity was reached
(usually in less than 3min), the DAB-HCL solution was removed and the sections
were washed with 0.05M Tris pH 7.6/7.5% Sucrose to halt the reaction. A final
series of washes in 0.05M Tris pH 7.6 was then performed to prepare the sections
for embedding.
DAB-HCL-treated sections were washed in 0.1M sodium cacodylate and then
incubated with 1% osmium tetroxide/0.1M sodium cacodylate. The sections were
then put through a series of dehydration washes in ethanol and infiltrated with
eponate resin. Eponate-infiltrated sections were placed flat on slides in drops of
eponate, cover-slipped and baked at 60 C overnight. The resulting eponate films
containing the sections were then removed from the coverslip and slide. Regions
containing the IS were then isolated and cut out of the film and placed flat in
column molds in eponate and baked again overnight at 60 C.
Sections embedded in column molds were sectioned on a Leica ultramicrotome.
Ultrathin (98 nm) sections were serially collected onto oval slot grids (two to three
individual sections per grid) and imaged using a JEM-1011 transmission electron
microscope (JEOL, Tokyo, Japan). Each images was then rotated and aligned using
the Fiji build of ImageJ and exported as individual tiff files. The resulting grey-scale
tiff files were inverted and cropped using Photoshop, and a 3D reconstruction was
rendered for each BCs using the Volocity software.
Intravital microscopy. KRT5Cre/tdTomatoLoxP mice were used in combination
with two-photon FIVM8–11 to visualize BC in real time in vivo. FVIM provides
significant advantages over single-photon confocal microscopy, including reduced
phototoxicity and photobleaching, as well as high lateral and axial resolution in
combination with large penetration depth. In addition, the epididymis provides
unique advantages for the study of intact tissues in vivo because it is located in the
scrotal sac, which can easily be externalized and is not subjected to motion artefacts
caused by heartbeat and respiration. KRT5Cre/tdTomatoLoxP mice underwent a
minimal surgical procedure to exteriorize one epididymis. A tail vein cannulation
was set up to deliver vehicle, the tyrosine kinase inhibitor, SKI606 (also known as
Bosutinib; 30mg kg 1), or additional pentobarbital if needed. Images of BCs from
the proximal epididymis (IS) were acquired on a customized Olympus
FV1000MPE multiphoton laser scanning confocal microscope using a  25
(numerical aperture¼ 1.05) water immersion objective. TdTomato was excited
with a tunable Ti:sapphire laser at 765 nm, and a FV10-MRV/G filter was used to
collect emitted light at 520±20 nm. A z-stack (z-step¼ 1 mm) of 512 512 images
(0.33 mm per pixel) was acquired every 15min. The length of each BC was
measured at each time point from six control and three SKI606-treated mice using
the Volocity (v. 6.3) software. After FIVM imaging, both epididymides were
collected and fixed by immersion, as described above.
PD325901 administration. Adult male WT mice were divided into a control
group (n¼ 10) and a PD 325901-treated group (n¼ 10). For the PD-treated group,
PD325901 was given by intraperitoneal (i.p.) injection with a dosage of 10mg kg 1
per day every 12 h for 12, 24 and 36 h (ref. 38). One epididymis was harvested and
fixed by immersion, and the other epididymis was processed for protein and
mRNA extractions. In a separate ‘recovery’ cohort, mice were treated with PD
325901 for 36 h, one epididymis was removed and fixed by immersion and the mice
were allowed to recover without further treatment for an additional 36 and 72 h.
The other epididymis was then harvested and fixed by immersion. Western blot
and PCR samples were collected in a separate group of mice.
Statistical analysis. Data were analysed by ANOVA followed by Student’s t-test
for unpaired values. A value of Po0.05 was considered significant. Data were
expressed as the means±s.e.
References
1. Shum, W. W. et al. Transepithelial projections from basal cells are luminal
sensors in pseudostratified epithelia. Cell 135, 1108–1117 (2008).
2. Kim, B., Roy, J., Shum, W. W., Da Silva, N. & Breton, S. Role of testicular
luminal factors on basal cell elongation and proliferation in the mouse
epididymis. Biol. Reprod. 92, 9 (2015).
3. Shum, W., Hill, E., Brown, D. & Breton, S. Plasticity of basal cells during
postnatal development in the rat epididymis. Reproduction 146, 455–469
(2013).
4. Shum, W. W. et al. Epithelial basal cells are distinct from dendritic cells and
macrophages in the mouse epididymis. Biol. Reprod. 90, 1–10 (2014).
5. Tata, P. R. et al. Dedifferentiation of committed epithelial cells into stem cells
in vivo. Nature 503, 218–223 (2013).
6. Veri, J. P., Hermo, L. & Robaire, B. Immunocytochemical localization of the Yf
subunit of glutathione S-transferase P shows regional variation in the staining
of epithelial cells of the testis, efferent ducts, and epididymis of the male rat.
J. Androl. 14, 23–44 (1993).
7. Drobizhev, M., Makarov, N. S., Tillo, S. E., Hughes, T. E. & Rebane, A. Two-
photon absorption properties of fluorescent proteins. Nat. Methods 8, 393–399
(2011).
8. Earley, S. et al. In vivo imaging of drug-induced mitochondrial outer membrane
permeabilization at single-cell resolution. Cancer. Res. 72, 2949–2956 (2012).
9. Lee, S. et al. Real-time in vivo imaging of the beating mouse heart at
microscopic resolution. Nat. Commun. 3, 1054 (2012).
10. Pittet, M. J. & Weissleder, R. Intravital imaging. Cell 147, 983–991 (2011).
11. Lee, S., Vinegoni, C., Sebas, M. & Weissleder, R. Automated motion artifact
removal for intravital microscopy, without a priori information. Sci. Rep. 4,
4507 (2014).
12. US Food and Drug Administration, C. f. D. E. a. R. Pharmacology Review(s) for
Bosulif (bosutinib). Application No. 203341. http://www.accessdata.fda.gov/
drugsatfda_docs/nda/2012/203341Orig1s000PharmR.pdf (2012).
13. Jun, H. J. et al. ROS1 signaling regulates epithelial differentiation in the
epididymis. Endocrinology 155, 3661–3673 (2014).
14. Krapf, D. et al. cSrc is necessary for epididymal development and is
incorporated into sperm during epididymal transit. Dev. Biol. 369, 43–53
(2012).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10666
10 NATURE COMMUNICATIONS | 7:10666 |DOI: 10.1038/ncomms10666 | www.nature.com/naturecommunications
15. Sonnenberg-Riethmacher, E., Walter, B., Riethmacher, D., Godecke, S. &
Birchmeier, C. The c-ros tyrosine kinase receptor controls regionalization and
differentiation of epithelial cells in the epididymis. Genes Dev. 10, 1184–1193
(1996).
16. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption
of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693–702
(1991).
17. Yeung, C.-H. et al. Increased luminal pH in the epididymis of infertile c-ros
knockout mice and the expression of sodium-hydrogen exchangers and
vacuolar proton pump Hþ -ATPase. Mol. Reprod. Dev. 68, 159–168 (2004).
18. Golas, J. M. et al. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of
Src and Abl kinases, is a potent antiproliferative agent against chronic
myelogenous leukemia cells in culture and causes regression of K562 xenografts
in nude mice. Cancer Res. 63, 375–381 (2003).
19. Stival, C. et al. Src kinase is the connecting player between protein kinase A
(PKA) activation and hyperpolarization through SLO3 potassium channel
regulation in mouse sperm. J. Biol. Chem. 290, 18855–18864 (2015).
20. Xu, B., Yang, L. & Hinton, B. T. The role of fibroblast growth factor receptor
substrate 2 (FRS2) in the regulation of two activity levels of the components of
the extracellular signal-regulated kinase (ERK) pathway in the mouse
epididymis. Biol. Reprod. 89, 48 (2013).
21. Xu, B. et al. Testicular lumicrine factors regulate ERK, STAT, and NFKB
pathways in the initial segment of the rat epididymis to prevent apoptosis. Biol.
Reprod. 84, 1282–1291 (2011).
22. Xu, B., Yang, L., Lye, R. J. & Hinton, B. T. p-MAPK1/3 and DUSP6 regulate
epididymal cell proliferation and survival in a region-specific manner in mice.
Biol. Reprod. 83, 807–817 (2010).
23. Hamzeh, M. & Robaire, B. Androgens activate mitogen-activated protein kinase
via epidermal growth factor receptor/insulin-like growth factor 1 receptor in
the mouse PC-1 cell line. J. Endocrinol. 209, 55–64 (2011).
24. Baker, M. A., Hetherington, L. & Aitken, R. J. Identification of SRC as a key
PKA-stimulated tyrosine kinase involved in the capacitation-associated
hyperactivation of murine spermatozoa. J. Cell Sci. 119, 3182–3192 (2006).
25. Schwartzberg, P. L. et al. Rescue of osteoclast function by transgenic express-
ion of kinase-deficient Src in src-/- mutant mice. Genes Dev. 11, 2635–2844
(1997).
26. Krause, M. & Gautreau, A. Steering cell migration: lamellipodium dynamics
and the regulation of directional persistence. Nat. Rev. Mol. Cell Biol. 15,
577–590 (2014).
27. Larive, R. M., Baisamy, L., Urbach, S., Coopman, P. & Bettache, N. Cell
membrane extensions, generated by mechanical constraint, are associated with
a sustained lipid raft patching and an increased cell signaling. Biochim. Biophys.
Acta 1798, 389–400 (2010).
28. Panopoulos, A., Howell, M., Fotedar, R. & Margolis, R. L. Glioblastoma
motility occurs in the absence of actin polymer. Mol. Biol. Cell 22, 2212–2220
(2011).
29. Stover, D. R., Becker, M., Liebetanz, J. & Lydon, N. B. Src phosphorylation of
the epidermal growth factor receptor at novel sites mediates receptor
interaction with Src and P85 alpha. J. Biol. Chem. 270, 15591–15597 (1995).
30. Biscardi, J. S. et al. c-Src-mediated phosphorylation of the epidermal growth
factor receptor on Tyr845 and Tyr1101 is associated with modulation of
receptor function. J. Biol. Chem. 274, 8335–8343 (1999).
31. Biscardi, J. S., Ishizawar, R. C., Silva, C. M. & Parsons, S. J. Tyrosine kinase
signalling in breast cancer: epidermal growth factor receptor and c-Src
interactions in breast cancer. Breast Cancer Res. 2, 203–210 (2000).
32. Elson, S. D., Browne, C. A. & Thorburn, G. D. Identification of epidermal
growth factor-like activity in human male reproductive tissues and fluids.
J. Clin. Endocrinol. Metab. 58, 589–594 (1984).
33. Dube, E., Dufresne, J., Chan, P. T. & Cyr, D. G. Epidermal growth factor
regulates connexin 43 in the human epididymis: role of gap junctions in
azoospermia. Hum. Reprod. 27, 2285–2296 (2012).
34. Cyr, D. G. Connexins and pannexins. Spermatogenesis 1, 325–338 (2011).
35. Yeung, C. et al. Basal cells of the human epididymis--antigenic and
ultrastructural similarities to tissue-fixed macrophages. Biol. Reprod. 50,
917–926 (1994).
36. Beaulieu, V. et al. Modulation of the actin cytoskeleton via gelsolin regulates
vacuolar Hþ -ATPase recycling. J. Biol. Chem. 280, 8452–8463 (2005).
37. Roy, J. W. et al. Circulating aldosterone induces the apical accumulation of the
proton pumping V-ATPase and increases proton secretion in clear cells in the
caput epididymis. Am. J. Physiol. Cell Physiol. 305, C436–C446 (2013).
38. Mulholland, D. J. et al. Pten loss and RAS/MAPK activation cooperate to
promote EMT and metastasis initiated from prostate cancer stem/progenitor
cells. Cancer Res. 72, 1878–1889 (2012).
Acknowledgements
This work was supported by NIH grants HD040793 and DK097124 (to S.B.), and
P50CA086355 and S10RR0266360 (to R.W.) The Microscopy Core facility of the MGH
Program in Membrane Biology receives support from the Boston Area Diabetes and
Endocrinology Research Center (DK57521) and the Center for the Study of Inflamma-
tory Bowel Disease (DK43351). The Nikon A1R confocal in the PMB Microscopy Core
was purchased using an NIH Shared Instrumentation Grant S10 RR031563-01. S.B. is a
recipient of the Charles and Ann Sanders Research Scholar Award at MGH.
Author contributions
J.R., B.K. and S.B. designed the study; J.R., B.K., E.H. and C.V. performed the experi-
ments; J.R., D.B. and S.B. wrote the manuscript; J.R., B.K., P.V., D.K., C.V., R.W., D.B.
and S.B. read and commented on various drafts of the manuscript.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Roy, J. et al. Tyrosine kinase-mediated axial motility of basal
cells revealed by intravital imaging. Nat. Commun. 7:10666 doi: 10.1038/ncomms10666
(2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10666 ARTICLE
NATURE COMMUNICATIONS | 7:10666 |DOI: 10.1038/ncomms10666 | www.nature.com/naturecommunications 11
